| 摘要 |
PROBLEM TO BE SOLVED: To provide a new medicinal composition for effective treatment of various eye diseases such as glaucoma, glaucoma with elevated or normal intraocular pressure, neovascular senile macular degeneration, senile macular degeneration, central chorioretinitis, macular degeneration, senile macular degeneration, macular hole, cataract, senile cataract, fundal hemorrhage, central retinal artery occlusion, fundal arteriosclerosis, photopsia, diabetic retinopathy, chorioretinal atrophy, fundal diseases due to myopia, neovascular diseases of retina and chorioid membrane, retinoblastoma, malignant melanoma or the other malignant tumors, cataract due to ovary removal, cataract due to TGFβ, macular fibrous proliferation (macular packer), central retinal vein (branch) occlusion, retinal break, retinal detachment, proliferative retinopathy, retinitis pigmentosa, corneitis, corneal clouding (haze), corneal erosion, corneal epithelial abrasion, corneal ulcer, Mooren's ulcer (rodent corneal ulcer), corneal endothelial cell dystrophy or omission, corneal dystrophy, epidemic keratoconjunctivitis, chalazion, iritis, uveitis, autoimmune disease, chorioretinitis, iridocyclitis, asthenopia, constriction of visual field due to various diseases, atrophy of optic nerve, optic neuritis, ischemic optic neuropathy, decreased dynamic visual acuity, achromatopsy, and various eye diseases such as ametropia including presbyopia, myopia, hyperopia and astigmatism. SOLUTION: The therapeutic composition for eye diseases includes a sirtuin activating substance. Preferably, the therapeutic composition for eye diseases including the sirtuin activating substance is selected from the group consisting of trans-stilbene derivatives such as resveratrol and piceatannol, jasmone, jasmonic acid or derivatives thereof, and salicylic acid or derivatives thereof. COPYRIGHT: (C)2011,JPO&INPIT
|
